VANCOUVER, BC – GeniusHealth Therapeutics, a company dedicated to revolutionizing healthcare for individuals with neurodevelopmental disorders (NDD), is proud to announce the appointment of Dr. Zhimin Huo as the Cheif Technology office.
With more than 25 years of experience, Dr. Huo has established herself as a leading expert in driving innovation, scientific research, and product development to address real-world problems by applying AI technologies. She has worked for decades on computer-aided diagnosis, machine learning, and deep learning for disease diagnosis, management, and treatment. Dr. Huo has an impressive record of successfully developing and implementing AI products that solve practical problems in various real-world clinical use scenarios. Additionally, she is experienced in building high-performance teams and leading cross-functional teams to drive the research and product development process, from initial product concepts, prototypes, and clinical trials to robust products in the market, for FDA-regulated medical devices.
“We are excited to have Dr. Huo join our team at GeniusHealth,” said Andy Yu, CEO of GeniusHealth Therapeutics. “Neurodevelopmental disorders have become a serious health challenge, particularly for children between the ages of 3 and 17. We believe that with Dr. Huo’s expertise, we can bring state-of-the-art digital medicine to patients, which will significantly improve diagnostics and personalized treatments for NDDs.”
GeniusHealth Therapeutics was founded with the mission of helping every behavioral and neuro-disorder genius achieve their life goals. The company is committed to challenging the status quo of medicine and care delivery to help people living with ADHD, ASD, and other cognitive impairments. GeniusHealth Therapeutics aims to bring together top scientists and clinical know-how with great multicultural experiences to forever change how medicine is designed and delivered.“Over the past three decades, the number of people impacted by NDD (neurodevelopmental disorders) has doubled. However, the diagnostics and treatment options have not been updated to meet the demand, leading to low treatment rates and high misdiagnosis rates” said Dr. Zhimin Huo, as the newly appointed Chief Technology Officer at GeniusHealth. ” I am excited to join the GeniusHealth team to develop cutting-edge digital medicine solutions for cognitive impairments and make a meaningful impact in the lives of those affected by NDDs”
As Chief Technology officer, Dr. Huo will be responsible for leading the development of state-of-the-art digital medicine solutions for NDDs at GeniusHealth Therapeutics. Her experience and leadership will be instrumental in advancing the company’s mission to improve the lives of individuals with neurodevelopmental disorders.
For more information on GeniusHealth Therapeutics and its mission to revolutionize healthcare for individuals with neurodevelopmental disorders, please visit www.geniushealth.care